Bexsero is an FDA-approved vaccine to prevent invasive disease caused by Neisseria meningitidis serogroup B.
It was approved for use starting in 2014.
Bexsero is approved for use in individuals 10 through 25 years of age.
The 2 doses of Bexsero can be completed in 1 month.
The meningitis vaccine most people may have received when they were younger covered meningitis ACWY, not meningitis B.